Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

The Herald-Sun, Durham, N.C., Business Briefs Column

Posted on: Friday, 13 January 2006, 21:00 CST

By The Herald-Sun, Durham, N.C.

Jan. 13--BURT'S BEES SETTLES: Durham-based Burt's Bees has paid $110,000 to the Business Software Alliance, a software industry group, to settle claims the company had unlicensed copies of Microsoft, Adobe and Apple software installed on its computers, the organization said Thursday.

The group, which represents software manufacturers, said it was notified via its online reporting system that the personal care products company was using unlicensed copies of software. After the group's attorneys contacted Burt's Bees, it cooperated and conducted an audit, BSA said in a release.

The organization also reported that two Raleigh firms, Patriot Performance Materials and Stock Building Supply, paid a combined total of $155,000 to settle claims they had unlicensed copies of software programs.

BSA offers rewards of up to $50,000 for qualifying reports of unlicensed software use in the United States.

INTEGRIAN GETS SHARES: Durham-based Integrian, a developer of mobile digital video solutions, said Thursday it has acquired all issued shares of Innovonics Ltd., an Australian technology company.

Innovonics designs, makes and installs transportation surveillance systems. Integrian's customers include the public safety and transportation markets. Financial terms of the acquisition were not disclosed.

Last year, Integrian raised $13 million in venture capital and acquired Digital Safety Technologies, a Nashville, Tenn.-based company that sells digital video surveillance systems.

ALPHAVAX TIGHTENS TIES: AlphaVax, a Research Triangle Park-based vaccine developer, said Thursday it has enhanced an existing license agreement with Wyeth, a global pharmaceutical company.

The original 1998 agreement provided Wyeth with access to AlphaVax technologies used to develop vaccines for selected infectious diseases.

The new license refocuses the target disease fields and provides Wyeth with exclusive access to all relevant AlphaVax technologies regarding those disease fields.

The new agreement includes an equity investment in AlphaVax by Wyeth, but the companies did not disclose the financial terms.

From staff reports

-----

To see more of The Herald-Sun, or to subscribe to the newspaper, go to http://www.herald-sun.com.

Copyright (c) 2006, The Herald-Sun, Durham, N.C.

Distributed by Knight Ridder/Tribune Business News.

For information on republishing this content, contact us at (800) 661-2511 (U.S.), (213) 237-4914 (worldwide), fax (213) 237-6515, or e-mail reprints@krtinfo.com.

MSFT, ADBE, AAPL, 6689, WYE,


Source: The Herald-Sun

More News in this Category


Related Articles



Rating: 3.1 / 5 (17 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required